09/09/2018 With reference to the agreement signed on 19/04/2017 with the Greek company DEMO SA and the start of sales of Deferoxamine Noridem 2 g on 30/05/2017, C.F.I. SRL has also launched Deferoxamine Noridem 500 mg in the Italian market. Deferoxamine mesylate is indicated for the treatment of acute iron intoxication and of chronic iron [...]
30/05/2017 With reference to the agreement signed on 19/04/2017 with the Greek company DEMO SA, C.F.I. SRL has launched Deferoxamine Noridem 2 g in the Italian market. Deferoxamine mesylate is indicated for the treatment of acute iron intoxication and of chronic iron overload due to transfusion-dependent anemias.
C.F.I. SRL on May 2017 presents and inaugurates the new website in a more modern and contemporary version, with a layout compatible with most browsers and smartphones.
19/04/2017 C.F.I. Srl has signed an agreement with the Greek company Demo SA for the exclusive sales and marketing of Deferoxamine Noridem (generic injectable) in Italy. Deferoxamine mesylate is indicated for the treatment of acute iron intoxication and of chronic iron overload due to transfusion-dependent anemias.
28/02/2017 C.F.I. Srl has signed an agreement with the Italian company Industria Farmaceutica Galenica Senese Srl for the exclusive distribution of its entire range of infusion solutions for veterinary use in Italy. The products portfolio includes different solutions in glass bottles, polypropylene bottles and bags and are largely used in veterinary for many applications.
11/04/2016 C.F.I. Srl has signed an agreement with the English company Animalcare Ltd for the exclusive distribution of Isocare (isoflurane) for veterinary use in Italy. Isoflurane is used in veterinary as general inhalation anesthetic agent in several animal species.
22/12/2015 C.F.I. Srl has signed a distribution agreement with the Turkish company TMP Ektrakorporeal. TMP Ektrakorporeal will be responsible of the sales and marketing activity of hemofiltration solutions in double chamber bag with bicarbonate as buffer of C.F.I. Srl in Turkey. Hemofiltration solutions are indicated as replacement solutions in Continuous Renal Replacement Therapy (CRRT).
12/11/2014 C.F.I. Srl has signed an agreement with the Swiss company Stragen Pharma SA for the exclusive distribution of Urapidil Stragen (generic injectable) in Italy. Urapidil is a solution for infusion and is indicated for the treatment of hypertensive emergencies, severe and very severe forms of hypertensive disease, hypertension resistant to treatment.
